Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Icotinib Treat the Patient With Brain Metastasis EGFR-mutant Non Small Cell Lung Cancer Comparing With Whole Brain Radiotherapy

NCT01724801 is registered in ClinicalTrials.gov with Guangdong Association of Clinical Trials as lead sponsor.

NCT NCT01724801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01724801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Icotinib Treat the Patient With Brain Metastasis EGFR-mutant Non Small Cell Lung Cancer Comparing With Whole Brain Radiotherapy
Lead sponsor
Guangdong Association of Clinical Trials
Phase
Phase 3
Overall status
Completed
Start date
October 14, 2012
Completion date
September 14, 2016
Enrollment
176 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastasis, non small cell lung cancer